Immunic focusing on business development during Q4
Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive London after the Munich-based biotech company released a...
Source: proactiveinvestors.com
Progressive Multiple News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Progressive Multiple. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Progressive Multiple Today - Breaking & Trending Today
Immunic focusing on business development during Q4
Immunic Inc President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive London after the Munich-based biotech company released a third-quarter update.Dr Vitt starts by describing the...
Source: marketscreener.com
EQS-News: Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
Issuer: Immunic, Inc. / Key word(s): Study Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis 17.08.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Completes Enrollment of Its P...
Source: boersennews.de
Can vitamin D have positive effects on reducing cortical pathology, oxidative stress, and neurofilament light chain serum levels?
Researchers use an established murine model of cortical inflammatory demyelination to investigate the effects of vitamin D.
Source: news-medical.net
BrainStorm to Present Phase 2 Progressive MS Study Results in Oral Presentation at 37th Congress of ECTRIMS
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today...
Source: prnewswire.com